Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

  1. Home
  3. Silymarin Mitigates Toxic Effects Of Cyclophosphamide On Testicular Tissue And Sperm Parameters In Mice.
  1. Home
  3. Silymarin Mitigates Toxic Effects Of Cyclophosphamide On Testicular Tissue And Sperm Parameters In Mice.

Related Experiment Video

Functional Assessment of Kinesin-7 CENP-E in Spermatocytes Using In Vivo Inhibition, Immunofluorescence and Flow Cytometry
09:41

Functional Assessment of Kinesin-7 CENP-E in Spermatocytes Using In Vivo Inhibition, Immunofluorescence and Flow Cytometry

Published on: December 28, 2021

1.8K

Silymarin mitigates toxic effects of cyclophosphamide on testicular tissue and sperm parameters in mice.

Zahra Shaker Kordedeh1, Saeid Ghorbani1, Sepideh Ahmadi1

  • 1Department of Biology, Faculty of Science, Arak University, Arak, Iran.

Reproductive Biology
|September 1, 2024

View abstract on PubMed

Summary
This summary is machine-generated.

Silymarin, an antioxidant, effectively mitigates cyclophosphamide-induced testicular damage and sperm quality reduction in mice. This study highlights silymarin

Keywords:
CyclophosphamideMiceSilymarinSperm parametersStereologyTestis

More Related Videos

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
14:26

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice

Published on: April 7, 2014

15.4K
A Syngeneic Murine Model of Endometriosis using Naturally Cycling Mice
07:12

A Syngeneic Murine Model of Endometriosis using Naturally Cycling Mice

Published on: November 24, 2020

5.1K

Related Experiment Videos

Functional Assessment of Kinesin-7 CENP-E in Spermatocytes Using In Vivo Inhibition, Immunofluorescence and Flow Cytometry
09:41

Functional Assessment of Kinesin-7 CENP-E in Spermatocytes Using In Vivo Inhibition, Immunofluorescence and Flow Cytometry

Published on: December 28, 2021

1.8K
A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
14:26

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice

Published on: April 7, 2014

15.4K
A Syngeneic Murine Model of Endometriosis using Naturally Cycling Mice
07:12

A Syngeneic Murine Model of Endometriosis using Naturally Cycling Mice

Published on: November 24, 2020

5.1K

Area of Science:

  • Reproductive Toxicology
  • Oxidative Stress Research
  • Pharmacology

Background:

  • Cyclophosphamide (chemotherapy drug) induces significant oxidative stress in sperm and testicular tissues.
  • This oxidative stress can lead to impaired sperm quality and testicular function.
  • Antioxidants may offer a protective strategy against drug-induced reproductive toxicity.

Purpose of the Study:

  • To evaluate the protective effects of silymarin, a potent antioxidant, against cyclophosphamide-induced testicular toxicity in mice.
  • To assess the impact of silymarin on sperm parameters and testicular histology following cyclophosphamide treatment.

Main Methods:

  • NMRI adult male mice were divided into four groups: control, cyclophosphamide, cyclophosphamide + silymarin, and silymarin.
  • Cyclophosphamide was administered intraperitoneally (100 mg/kg weekly). Silymarin was given intraperitoneally (200 mg/kg every other day).
  • Sperm parameters, stereological studies of testicular tissue, and biochemical factors (testosterone, TAC, MDA) were assessed after 35 days.

    • Main Results:

    • Cyclophosphamide treatment significantly reduced testicular volume, seminiferous tubule components, Leydig cells, Sertoli cells, and sperm parameters.
    • Cyclophosphamide also decreased testosterone levels and total antioxidant capacity (TAC), while increasing malondialdehyde (MDA) levels.
    • Co-administration of silymarin significantly mitigated these adverse effects induced by cyclophosphamide.

    Conclusions:

    • Silymarin demonstrates significant antioxidant properties that protect testicular tissue and sperm parameters from cyclophosphamide-induced damage.
    • Silymarin can mitigate chemotherapy-induced reproductive toxicity, suggesting its potential therapeutic role.
    • Further research into silymarin's efficacy in clinical settings for managing chemotherapy side effects is warranted.